Non-transferrin bound labile plasma iron and iron overload in Sickle Cell Disease: a comparative study between Sickle Cell Disease and β thalassemic patients

被引:38
作者
Koren, Ariel [1 ,2 ,3 ]
Fink, Daniel
Admoni, Osnat [4 ]
Tennenbaum-Rakover, Yardena [3 ,4 ]
Levin, Carina [1 ,2 ,3 ]
机构
[1] Ha Emek Med Ctr, Pediat Hematol Unit, IL-18101 Afula, Israel
[2] Ha Emek Med Ctr, Pediat Dept B, IL-18101 Afula, Israel
[3] Technion Israel Inst Technol, Ruth & Baruch Rappaport Sch Med, Haifa, Israel
[4] Ha Emek Med Ctr, Pediat Endocrinol Unit, IL-18101 Afula, Israel
关键词
sickle cell anemia; iron overload; non-transferrin bound iron; REGULATORY PROTEIN; MYOCARDIAL IRON; EXPRESSION; HEPCIDIN; THERAPY; TRANSFUSION; MORBIDITY; MORTALITY; LPI;
D O I
10.1111/j.1600-0609.2009.01342.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Blood transfusions are the standard of care in beta thalassemia and transfusions are also indicated in sickle cell disease (SCD) patients with hypersplenism, recurrent vaso-occlusive crises and for stroke prevention. Iron overload caused by blood transfusions in thalassemia and in SCD may affect morbidity and mortality. Recent studies of iron overload in SCD suggest that the biologic features of SCD and the chronic inflammatory state may protect SCD patients from iron damage. Designs and methods: In view of the controversy regarding the effect of iron overload in patients with SCD we studied the iron status, including non-transferrin bound iron (NTBI) and labile plasma iron (LPI) levels in a cohort of 36 SCD patients and compare the results with 43 thalassemia patients. Results: Our results indicate that none of the SCD patients had clinical symptoms of iron overload. Only two SCD patients had NTBI values in the gray zone (0.4 units) and none had positive values. By contrast, 14 patients with thalassemia major and three with thalassemia intermedia had NTBI values above 0.6, level that are in the positive pathological range. Similarly, four thalassemia patients, but only one SCD patient had positive LPI levels. Conclusions: The parameters of iron status in SCD patients, even after frequent transfusions are different when compared to patients with thalassemia. The low NTBI and LPI levels found in patients with SCD are in keeping with the absence of clinical signs of iron overload in this disease.
引用
收藏
页码:72 / 78
页数:7
相关论文
共 23 条
[1]   SERUM NON-TRANSFERRIN-BOUND IRON IN BETA-THALASSEMIA MAJOR PATIENTS TREATED WITH DESFERRIOXAMINE AND L1 [J].
ALREFAIE, FN ;
WICKENS, DG ;
WONKE, B ;
KONTOGHIORGHES, GJ ;
HOFFBRAND, AV .
BRITISH JOURNAL OF HAEMATOLOGY, 1992, 82 (02) :431-436
[2]   Iron overload is a determinant of morbidity and mortality in adult patients with sickle cell disease [J].
Ballas, SK .
SEMINARS IN HEMATOLOGY, 2001, 38 (01) :30-36
[3]  
Blum A, 2005, HAEMA, V8, P462
[4]   LPI-labile plasma iron in iron overload [J].
Cabantchik, ZI ;
Breuer, W ;
Zanninelli, G ;
Cianciulli, R .
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2005, 18 (02) :277-287
[5]   Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload [J].
Fung, Ellen B. ;
Harmatz, Paul ;
Milet, Meredith ;
Ballas, Samir K. ;
De Castro, Laura ;
Hagar, Ward ;
Owen, William ;
Olivieri, Nancy ;
Smith-Whitley, Kim ;
Darbari, Deepika ;
Wang, Winfred ;
Vichinsky, Elliott .
AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (04) :255-265
[6]  
GHOTI H, 2008, T2 MRI PROVIDES EVID
[7]   NONSPECIFIC SERUM IRON IN THALASSEMIA - ABNORMAL SERUM IRON FRACTION OF POTENTIAL TOXICITY [J].
HERSHKO, C ;
GRAHAM, G ;
BATES, GW ;
RACHMILEWITZ, EA .
BRITISH JOURNAL OF HAEMATOLOGY, 1978, 40 (02) :255-263
[8]   Iron homeostasis during transfusional iron overload in β-thalassemia and sickle cell disease:: Changes in iron regulatory protein, hepcidin, and ferritin expression [J].
Jenkins, Zandra A. ;
Hagar, Ward ;
Bowlus, Christopher L. ;
Johansson, Hans E. ;
Harmatz, Paul ;
Vichinsky, Elliott P. ;
Theil, Elizabeth C. .
PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2007, 24 (04) :237-243
[9]   Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool [J].
Jensen, PD ;
Jensen, FT ;
Christensen, T ;
Eiskjaer, H ;
Baandrup, U ;
Nielsen, JL .
BLOOD, 2003, 101 (11) :4632-4639
[10]   Liver biopsy results in patients with sickle cell disease on chronic transfusions: Poor correlation with ferritin levels [J].
Karam, Lina B. ;
Disco, Deborah ;
Jackson, Sherron M. ;
Lewin, David ;
Mckie, Virgil ;
Baker, Robert D. ;
Baker, Susan S. ;
Laver, Joseph H. ;
Nietert, Paul J. ;
Abboud, Miguel R. .
PEDIATRIC BLOOD & CANCER, 2008, 50 (01) :62-65